hotspot -WSS

hotspot

author：comprehensive 2025-08-26 10:53:06 - browse：1

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Changes to biosimilar regulatory framework must prioritize patients

WSS

Democrats decry new health bill for going easy on private equity

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Senators: Long

STAT Report: Patient voices and perspectives

Roche’s Alnylam deal shows drug firms interested in heart drugs

Thermo Fisher plant for manufacturing gene therapies to expand

explore

hotspot

The contrarian view of Viking Therapeutics

focus

Hollywood unions extend contract negotiations for actors

Biotech lab space demand falls sharply

United colonoscopy coverage change 'may cost lives,' doctors say

What to watch for from Zogenix and Amicus clinical trials

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How Vertex's cystic fibrosis drug is changing patients' lives

Jerome Adams on the need for new antivirals for Covid

Changes to biosimilar regulatory framework must prioritize patients

Tori Bowie and the unacceptable rates of Black maternal death

Ukraine and a new approach to mental health in war

entertainment

Dems pitch expanding Medicare power to negotiate drug prices

'Investigate these claims': UFO transparency at center of House hearing

CDC advisers recommend seasonal use of Pfizer RSV shot

UHS says company favors patients whose insurance pays more

EpiPen alternative approval delay highlights citizen petition issue

Emergency workers more likely to restrain Black patients: study

entertainment

Wikipedia

leisure time

hotspot